These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8255752)

  • 1. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro.
    Hagemeier C; Cook A; Kouzarides T
    Nucleic Acids Res; 1993 Nov; 21(22):4998-5004. PubMed ID: 8255752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.
    Kim YW; Otterson GA; Kratzke RA; Coxon AB; Kaye FJ
    Mol Cell Biol; 1994 Nov; 14(11):7256-64. PubMed ID: 7935440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
    Flemington EK; Speck SH; Kaelin WG
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):6914-8. PubMed ID: 8346196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
    Sellers WR; Rodgers JW; Kaelin WG
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.
    Pearson A; Greenblatt J
    Oncogene; 1997 Nov; 15(22):2643-58. PubMed ID: 9400991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma protein recruits histone deacetylase to repress transcription.
    Brehm A; Miska EA; McCance DJ; Reid JL; Bannister AJ; Kouzarides T
    Nature; 1998 Feb; 391(6667):597-601. PubMed ID: 9468139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
    Arroyo M; Raychaudhuri P
    Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor.
    Lee C; Chang JH; Lee HS; Cho Y
    Genes Dev; 2002 Dec; 16(24):3199-212. PubMed ID: 12502741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
    Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
    Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of active transcriptional repression by the retinoblastoma protein.
    Weintraub SJ; Chow KN; Luo RX; Zhang SH; He S; Dean DC
    Nature; 1995 Jun; 375(6534):812-5. PubMed ID: 7596417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.
    Hsieh JK; Fredersdorf S; Kouzarides T; Martin K; Lu X
    Genes Dev; 1997 Jul; 11(14):1840-52. PubMed ID: 9242491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter-dependent photocross-linking of the acidic transcriptional activator E2F-1 to the TATA-binding protein.
    Emili A; Ingles CJ
    J Biol Chem; 1995 Jun; 270(23):13674-80. PubMed ID: 7775419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis.
    Shan B; Durfee T; Lee WH
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):679-84. PubMed ID: 8570615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
    Wang S; Nath N; Adlam M; Chellappan S
    Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RB and hbrm cooperate to repress the activation functions of E2F1.
    Trouche D; Le Chalony C; Muchardt C; Yaniv M; Kouzarides T
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11268-73. PubMed ID: 9326598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The retinoblastoma protein region required for interaction with the E2F transcription factor includes the T/E1A binding and carboxy-terminal sequences.
    Huang S; Shin E; Sheppard KA; Chokroverty L; Shan B; Qian YW; Lee EY; Yee AS
    DNA Cell Biol; 1992 Sep; 11(7):539-48. PubMed ID: 1388726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor E2F-1 is a downstream target of RB action.
    Qin XQ; Livingston DM; Ewen M; Sellers WR; Arany Z; Kaelin WG
    Mol Cell Biol; 1995 Feb; 15(2):742-55. PubMed ID: 7823942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
    Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.